RMC-6291 CAS No.2641998-63-0
RMC-6291 CAS No.2641998-63-0
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-R-2975 | 1mg | 410.00 | + Add to cart |
|
R-R-2975 | 2mg | 710.00 | + Add to cart |
|
|
Product description
RMC-6291/CAS No.2641998-63-0 is an orally active and covalent inhibitor of KRASG12C(ON). RMC-6291 forms a tri-complex within tumor cells between KRASG12C(ON) and cyclophilin A (CypA). Thus, RMC-6291 prevents KRASG12C(ON) from signaling via steric blockade of RAS effector binding. RMC-6291 inhibits ERK signaling and induced apoptosis in KRASG12C-mutant H358 cells. RMC-6291 also inhibits the proliferation of KRASG12C mutant cells with a median IC50 of 0.11 nM.
Appearance | N/A |
---|---|
Molecular Weight | 1012.00 |
Purity | >90% |
CAS | 2641998-63-0 |
Formula | C55H78FN9O8 |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 2 weeks |
Stability | 1 year |
Document
Related Product